Clinical Study of Jinsang Liyan Capsules Combined With PPI in the Treatment of LPRD
Status:
Not yet recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to compare the efficacy of Jinsang Liyan capsule in
combination with PPI versus PPI alone for the treatment of Laryngopharyngeal Reflux Disease
(LPRD).
Participants will be randomly assigned in a 1:1 ratio to the experimental group or the
control group. The experimental group was treated with Jinsangliyan capsule + rabeprazole
enteric-coated tablets, and the control group was treated with Jinsangliyan capsule placebo +
rabeprazole enteric-coated tablets. Participants were followed up at 4 weeks and 8 weeks
after taking the drug to evaluate the improvement of LPRD symptoms.
Researchers will compare Experimental group and control group to see if Jinsang Liyan capsule
combined with PPI treatment is superior to PPI treatment alone.